BibTex RIS Cite

Glutarik Asidüri Tip 2

Year 2012, Volume: 6 Issue: 3, 171 - 175, 01.06.2012

Abstract

Bir organik asit bozukluğu olan glutarik asidüri tip 2 otozomal resesif geçişli, yavaş seyirli nörodejeneratif bir metabolik hastalıktır. Multipl açil koenzim A dehidrogenaz eksikliği söz konusu olup elektron taşıyıcı flavoprotein (ETF) ve elektron taşıyıcı flavoprotein dehidrogenaz (ETF-DH) açil koenzim A dehidrogenazların eksikliğine neden olur. Neonatal başlangıçlı formda hastalar hipotoni, hipoglisemi ve metabolik asidoz ile; geç başlangıçlı formda ise hipoglisemi ile beraber proksimal miyopati ve tekrarlayan kusma epizotları ile başvurabilir. Karakteristik olarak terli ayak kokusu saptanır.Burada hayatın ilk yılında motor gelişim basamaklarında gecikme, bazen ateşli bazen de ateşsiz nöbetler ile ikinci yılda belirginleşen mental gerilik ve serumda artmış glutarik asit varlığı ile glutarik asidüri tip 2 tanısı alan, karnitin ve yoğun destek tedavisi ile klinik durumunda dramatik düzelme sağlanan bir olgu sunulmuştur.

References

  • Sztriha L, Gururaj A, Vreken P, Nork M, Lestringant G. L-2 hydroxyglutaric aciduria in two siblings. Pediatr Neurol 2002;27:141-144.
  • Mumtaz HA, Grupta V, Singh P, Marwaha RK, Khandelwal N. MR imaging findings of glutaric aciduria type II. Singapore Med J 2010; 51: 69-71.
  • Topçu M, Aydın Ö, Yalçınkaya C, Haliloğlu G, Aysun S, Anlar B, Topaloğlu H, Turanli G, Yalnizoğlu D, Kesimer M, Coşkun T. L-2 Hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 2005;47:1-7.
  • al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT. Glu- taric aciduria type II: observations in seven patients with neona- tal- and late-onset disease. J Perinatol. 2000; 20:120-128.
  • Gordon N. Glutaric aciduria types I and II. Brain Dev 2006;28: 136-140.
  • Barbot C, Fineza I, Diogo L, Maia M, Melo J, Guimarães A, Pires MM, Cardoso ML, Vilarinho L . L-2 Hydroxyglutaric aciduria: cli- nical, biochemical and magnetic resonance imaging in six Portugu- ese pediatric patients. Brain Dev 1997;19:268-273.
  • Liang WC, Tsai KB, Lai CL, Chen LH, Jong YJ. Riboflavin- responsive glutaric aciduria type II with recurrent pancreatitis. Pe- diatric Neurol 2004; 31: 218-221.
  • Barth PG, Wanders RJ, Scholte HR, Abeling N, Jakobs C, Schut- gens RB, Vreken P . L-2 Hydroxyglutaric aciduria and lactic acido- sis. J Inherit Metab Dis 1998; 21:251-254.
  • Moroni I, D’ Incerti L, Farina L, Farina L, Rimoldi M, Uziel G. Cli- nical, biochemical and neuroradiological findings in L-2 hydroxy- glutaric aciduria. Neurol Sci 2000;21:103-108.
  • Hoffman GF, Meier-Augensteni W, Stockler S, Stöckler S, Surtees R, Rating D, Nyhan WL. Physiology and pathophysiology of orga- nic acids in cerebrospinal fluid. J Inherit Metab Dis 1993;16:648- 669.

GLUTARIC ACIDURIA TYPE 2

Year 2012, Volume: 6 Issue: 3, 171 - 175, 01.06.2012

Abstract

Glutaric aciduria type 2, an organic acid disorder, is a neurodegenerative, slowly progressing metabolic disease inherited in an autosomal recessive pattern. There is multiple acyl co-enzyme A dehydrogenase deficiency and it leads to deficiencies of electron transferring flavoprotein (ETF) and electron transferring flavoprotein dehydrogenase (ETF-DH) acyl coenzyme A dehydrogenases. In neonatal-onset form, the patients present with hypotonia, hypoglycemia and metabolic acidosis, whereas in late-onset form the patients may develop proximal myopathy and recurring vomiting episodes along with hypoglycemia. Characteristically, sweaty foot odor is recognized.In this paper, we presented a patient diagnosed with glutaric aciduria type 2 by the presence of increased serum glutaric acid, motor developmental delay within the first year of life and mental retardation that had become evident in the second year of life along with febrile and nonfebrile convulsions, whose clinical status was dramatically improved with carnitine and intense supportive treatment

References

  • Sztriha L, Gururaj A, Vreken P, Nork M, Lestringant G. L-2 hydroxyglutaric aciduria in two siblings. Pediatr Neurol 2002;27:141-144.
  • Mumtaz HA, Grupta V, Singh P, Marwaha RK, Khandelwal N. MR imaging findings of glutaric aciduria type II. Singapore Med J 2010; 51: 69-71.
  • Topçu M, Aydın Ö, Yalçınkaya C, Haliloğlu G, Aysun S, Anlar B, Topaloğlu H, Turanli G, Yalnizoğlu D, Kesimer M, Coşkun T. L-2 Hydroxyglutaric aciduria: a report of 29 patients. Turk J Pediatr 2005;47:1-7.
  • al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT. Glu- taric aciduria type II: observations in seven patients with neona- tal- and late-onset disease. J Perinatol. 2000; 20:120-128.
  • Gordon N. Glutaric aciduria types I and II. Brain Dev 2006;28: 136-140.
  • Barbot C, Fineza I, Diogo L, Maia M, Melo J, Guimarães A, Pires MM, Cardoso ML, Vilarinho L . L-2 Hydroxyglutaric aciduria: cli- nical, biochemical and magnetic resonance imaging in six Portugu- ese pediatric patients. Brain Dev 1997;19:268-273.
  • Liang WC, Tsai KB, Lai CL, Chen LH, Jong YJ. Riboflavin- responsive glutaric aciduria type II with recurrent pancreatitis. Pe- diatric Neurol 2004; 31: 218-221.
  • Barth PG, Wanders RJ, Scholte HR, Abeling N, Jakobs C, Schut- gens RB, Vreken P . L-2 Hydroxyglutaric aciduria and lactic acido- sis. J Inherit Metab Dis 1998; 21:251-254.
  • Moroni I, D’ Incerti L, Farina L, Farina L, Rimoldi M, Uziel G. Cli- nical, biochemical and neuroradiological findings in L-2 hydroxy- glutaric aciduria. Neurol Sci 2000;21:103-108.
  • Hoffman GF, Meier-Augensteni W, Stockler S, Stöckler S, Surtees R, Rating D, Nyhan WL. Physiology and pathophysiology of orga- nic acids in cerebrospinal fluid. J Inherit Metab Dis 1993;16:648- 669.
There are 10 citations in total.

Details

Other ID JA36GC94UE
Journal Section Research Article
Authors

Murat Doğan This is me

Mehmet Selçuk Bektas This is me

Şekibe Zehra Doğan This is me

Yaşar Cesur This is me

Hüseyin Çaksen This is me

Eren Çağan This is me

Publication Date June 1, 2012
Submission Date June 1, 2012
Published in Issue Year 2012 Volume: 6 Issue: 3

Cite

Vancouver Doğan M, Bektas MS, Doğan ŞZ, Cesur Y, Çaksen H, Çağan E. GLUTARIC ACIDURIA TYPE 2. Türkiye Çocuk Hast Derg. 2012;6(3):171-5.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 6 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.